Daxor Announces First Marketing Success with the Blood Volume Analyzer BVA-100.NEW YORK--(BUSINESS WIRE)--Sept. 29, 1999-- Daxor Corporation has signed contracts for permanent placement of the Blood Volume Analyzer (BVA-100) with Lutheran Medical Center of New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. and Bergen Medical Imaging center of New Jersey. These instruments were previously beta-tested at these facilities and have now been converted into a reagent reagent /re·a·gent/ (re-a´jent) a substance used to produce a chemical reaction so as to detect, measure, produce, etc., other substances. re·a·gent n. loaner program. Under the reagent loaner program, the facility is obligated ob·li·gate tr.v. ob·li·gat·ed, ob·li·gat·ing, ob·li·gates 1. To bind, compel, or constrain by a social, legal, or moral tie. See Synonyms at force. 2. To cause to be grateful or indebted; oblige. to buy a certain number of kits for blood volume measurement. The Daxor Corporation maintains the equipment. The use of a reagent equipment loaner plan is a common marketing tool in the medical instrumentation industry. It enables the facility to avoid paying initial capital costs. The cost of the equipment is included in the reagent cost itself. The BVA-100, after FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clearance, was introduced in late 1998 and is now undergoing beta testing (programming) beta testing - Testing a pre-release (potentially unreliable) version of a piece of software by making it available to selected users. This term derives from early 1960s terminology for product cycle checkpoints, first used at IBM but later standard throughout the in 8 other hospitals. The Company anticipates additional announcements in the near future on sales or similar placements of instruments. Lutheran Medical Center is a major hospital that has previously reported on the successful use of the Blood Volume Analyzer (BVA-100) as a substitute for right-sided cardiac catheterization Cardiac Catheterization Definition Cardiac catheterization (also called heart catheterization) is a diagnostic procedure which does a comprehensive examination of how the heart and its blood vessels function. . The BVA-100 is patented in the U.S., European Common Market, and Japan. It is the first instrument capable of providing a rapid measurement of the total amount of blood in an individual patient. The Company is in the process of hiring five additional sales/marketing personnel for the New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of Metropolitan Region. The Company recently negotiated a marketing agreement with a Mid-Western distributor. On 9/24/99, the Company concluded its first marketing agreement with an overseas distributor. The Company has recently inaugurated a separate division called U.S. Internet Services, which provides specialized Internet services. The Company developed this division particularly to facilitate medical communication. The website includes many examples of medical cases from different institutions using the BVA-100. These reports and similar reports from other institutions are available on Daxor Corporation's website at www.daxor.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion